Odds ratios for SF-36 MCS (1.2 [0.8, 1.7]) at Week 26 were numerically higher but did not reach statistical significance.
← all excerpts
Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study.
1
—
—